297 related articles for article (PubMed ID: 32771067)
21. Roles of coactosin-like protein (CLP) and 5-lipoxygenase-activating protein (FLAP) in cellular leukotriene biosynthesis.
Basavarajappa D; Wan M; Lukic A; Steinhilber D; Samuelsson B; Rådmark O
Proc Natl Acad Sci U S A; 2014 Aug; 111(31):11371-6. PubMed ID: 25034252
[TBL] [Abstract][Full Text] [Related]
22. 5-Lipoxygenase-activating protein homodimer in human neutrophils: evidence for a role in leukotriene biosynthesis.
Plante H; Picard S; Mancini J; Borgeat P
Biochem J; 2006 Jan; 393(Pt 1):211-8. PubMed ID: 16144515
[TBL] [Abstract][Full Text] [Related]
23. Drug discovery approaches targeting 5-lipoxygenase-activating protein (FLAP) for inhibition of cellular leukotriene biosynthesis.
Gür ZT; Çalışkan B; Banoglu E
Eur J Med Chem; 2018 Jun; 153():34-48. PubMed ID: 28784429
[TBL] [Abstract][Full Text] [Related]
24. Pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors in the management of asthma.
Drazen JM
Pharmacotherapy; 1997; 17(1 Pt 2):22S-30S. PubMed ID: 9017785
[TBL] [Abstract][Full Text] [Related]
25. Leukotriene synthesis in U937 cells expressing recombinant 5-lipoxygenase.
Kargman S; Rousseau P; Reid GK; Rouzer CA; Mancini JA; Rands E; Dixon RA; Diehl RE; Léveillé C; Nathaniel D
J Lipid Mediat; 1993 May; 7(1):31-45. PubMed ID: 8358023
[TBL] [Abstract][Full Text] [Related]
26. 5-lipoxygenase-activating protein stimulates the utilization of arachidonic acid by 5-lipoxygenase.
Abramovitz M; Wong E; Cox ME; Richardson CD; Li C; Vickers PJ
Eur J Biochem; 1993 Jul; 215(1):105-11. PubMed ID: 8344271
[TBL] [Abstract][Full Text] [Related]
27. The nuclear membrane organization of leukotriene synthesis.
Mandal AK; Jones PB; Bair AM; Christmas P; Miller D; Yamin TT; Wisniewski D; Menke J; Evans JF; Hyman BT; Bacskai B; Chen M; Lee DM; Nikolic B; Soberman RJ
Proc Natl Acad Sci U S A; 2008 Dec; 105(51):20434-9. PubMed ID: 19075240
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the interaction of human 5-lipoxygenase with its activating protein FLAP.
Häfner AK; Gerstmeier J; Hörnig M; George S; Ball AK; Schröder M; Garscha U; Werz O; Steinhilber D
Biochim Biophys Acta; 2015 Nov; 1851(11):1465-72. PubMed ID: 26327594
[TBL] [Abstract][Full Text] [Related]
29. Placenta growth factor induces 5-lipoxygenase-activating protein to increase leukotriene formation in sickle cell disease.
Patel N; Gonsalves CS; Yang M; Malik P; Kalra VK
Blood; 2009 Jan; 113(5):1129-38. PubMed ID: 18945963
[TBL] [Abstract][Full Text] [Related]
30. A novel therapeutic potential of cysteinyl leukotrienes and their receptors modulation in the neurological complications associated with Alzheimer's disease.
Rahman SO; Singh RK; Hussain S; Akhtar M; Najmi AK
Eur J Pharmacol; 2019 Jan; 842():208-220. PubMed ID: 30389631
[TBL] [Abstract][Full Text] [Related]
31. 5-Lipoxygenase: a target for antiinflammatory drugs revisited.
Steinhilber D
Curr Med Chem; 1999 Jan; 6(1):71-85. PubMed ID: 9873115
[TBL] [Abstract][Full Text] [Related]
32. Activation of 5-lipoxygenase after oxygen-glucose deprivation is partly mediated via NMDA receptor in rat cortical neurons.
Ge QF; Wei EQ; Zhang WP; Hu X; Huang XJ; Zhang L; Song Y; Ma ZQ; Chen Z; Luo JH
J Neurochem; 2006 May; 97(4):992-1004. PubMed ID: 16606359
[TBL] [Abstract][Full Text] [Related]
33. Protection of dopaminergic neurons by 5-lipoxygenase inhibitor.
Kang KH; Liou HH; Hour MJ; Liou HC; Fu WM
Neuropharmacology; 2013 Oct; 73():380-7. PubMed ID: 23800665
[TBL] [Abstract][Full Text] [Related]
34. Thrombin stimulates activation of the cerebral 5-lipoxygenase pathway during blood-brain cell contact.
Winking M; Heldt RM; Simmet T
J Cereb Blood Flow Metab; 1996 Jul; 16(4):737-45. PubMed ID: 8964815
[TBL] [Abstract][Full Text] [Related]
35. Impact of Arachidonic Acid and the Leukotriene Signaling Pathway on Vasculogenesis of Mouse Embryonic Stem Cells.
Huang YH; Sharifpanah F; Becker S; Wartenberg M; Sauer H
Cells Tissues Organs; 2016; 201(5):319-32. PubMed ID: 27198524
[TBL] [Abstract][Full Text] [Related]
36. Expression of enzymes and receptors of the leukotriene pathway in human neuroblastoma promotes tumor survival and provides a target for therapy.
Sveinbjörnsson B; Rasmuson A; Baryawno N; Wan M; Pettersen I; Ponthan F; Orrego A; Haeggström JZ; Johnsen JI; Kogner P
FASEB J; 2008 Oct; 22(10):3525-36. PubMed ID: 18591367
[TBL] [Abstract][Full Text] [Related]
37. Androgen-mediated sex bias impairs efficiency of leukotriene biosynthesis inhibitors in males.
Pace S; Pergola C; Dehm F; Rossi A; Gerstmeier J; Troisi F; Pein H; Schaible AM; Weinigel C; Rummler S; Northoff H; Laufer S; Maier TJ; Rådmark O; Samuelsson B; Koeberle A; Sautebin L; Werz O
J Clin Invest; 2017 Aug; 127(8):3167-3176. PubMed ID: 28737505
[TBL] [Abstract][Full Text] [Related]
38. 5-lipoxygenase pathway and its downstream cysteinyl leukotrienes as potential therapeutic targets for Alzheimer's disease.
Chen F; Ghosh A; Lin J; Zhang C; Pan Y; Thakur A; Singh K; Hong H; Tang S
Brain Behav Immun; 2020 Aug; 88():844-855. PubMed ID: 32222525
[TBL] [Abstract][Full Text] [Related]
39. Roles of cysteinyl leukotrienes and their receptors in immune cell-related functions.
Kanaoka Y; Austen KF
Adv Immunol; 2019; 142():65-84. PubMed ID: 31296303
[TBL] [Abstract][Full Text] [Related]
40. Distribution of the cysteinyl leukotriene system components in the human, rat and mouse eye.
Brunner SM; Schrödl F; Preishuber-Pflügl J; Runge C; Koller A; Lenzhofer M; Reitsamer HA; Trost A
Exp Eye Res; 2023 Jul; 232():109517. PubMed ID: 37211287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
